These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 6840647

  • 41. [Long-term therapy of asthmoid diseases with asthma-bisolvan (N 67c-AST)].
    Pauly VR.
    Landarzt; 1968 Aug 20; 44(23):1120-1. PubMed ID: 5702788
    [No Abstract] [Full Text] [Related]

  • 42. [Fenspiride-a new alternative on the therapy of obstructive lung disease].
    Mihălţan F.
    Pneumologia; 2003 Aug 20; 52(2):123-5. PubMed ID: 14702716
    [No Abstract] [Full Text] [Related]

  • 43. Bronchodilators.
    Davies D.
    Practitioner; 1981 Oct 20; 225(1360):1397-402. PubMed ID: 6120508
    [No Abstract] [Full Text] [Related]

  • 44. [Current broncholytic and expectorant therapy of patients with chronic nonspecific lung diseases].
    Solopov VN, Kolganova NA, Chuchalin AG.
    Ter Arkh; 1987 Oct 20; 59(12):96-9. PubMed ID: 2965833
    [Abstract] [Full Text] [Related]

  • 45. [Obstructive diseases of the respiratory tract. 2. Stage classification of chronic bronchitis and therapy].
    Jelke G, Möller R, Schmidt K.
    Med Klin; 1975 Nov 14; 70(46):1883-7. PubMed ID: 241902
    [No Abstract] [Full Text] [Related]

  • 46. [Effect of the inhalation of an atropine derivative (ipratropium bromide) in powder form on respiratory mechanics in obstructive airway diseases].
    Götz R, Siemon G.
    Prax Klin Pneumol; 1983 Oct 14; 37 Suppl 1():927-8. PubMed ID: 6227883
    [No Abstract] [Full Text] [Related]

  • 47. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I.
    Fortschr Med; 1982 Mar 25; 100(12):547-50. PubMed ID: 7042500
    [No Abstract] [Full Text] [Related]

  • 48. [When are bronchodilator agents sufficient in asthma/chronic obstructive lung disease?].
    Ponsioen BP.
    Ned Tijdschr Geneeskd; 1995 Nov 18; 139(46):2390-1. PubMed ID: 7501082
    [No Abstract] [Full Text] [Related]

  • 49. COPD. Assessing functional status.
    Daly WJ.
    Hosp Pract (Off Ed); 1985 Mar 30; 20(3A):73-7, 82-5, 89-93. PubMed ID: 3932414
    [No Abstract] [Full Text] [Related]

  • 50. [Is routine monitoring of theophylline blood levels really effective?].
    Atsmon J, Priel IE, Dolev E.
    Harefuah; 1995 Nov 01; 129(9):304-8, 368. PubMed ID: 8549976
    [Abstract] [Full Text] [Related]

  • 51. How detrimental is chronic use of bronchodilators in asthma and chronic obstructive pulmonary disease?
    van Schayck CP, Cloosterman SG, Hofland ID, van Herwaarden CL, van Weel C.
    Am J Respir Crit Care Med; 1995 May 01; 151(5):1317-9. PubMed ID: 7735579
    [No Abstract] [Full Text] [Related]

  • 52. [Effect of theophylline-ethylenediamine in obstructive lung disease (author's transl)].
    Brossmann D, Ruf G, Wiessmann KJ.
    Dtsch Med Wochenschr; 1980 Mar 21; 105(12):410-3. PubMed ID: 7363785
    [Abstract] [Full Text] [Related]

  • 53. [Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases].
    Boulet LP, d'Amours P, Bérubé D, Rouleau M, Parent JG, Pelletier C, Touchette C.
    Union Med Can; 1994 Jan 21; 123(1):23-31. PubMed ID: 8109063
    [Abstract] [Full Text] [Related]

  • 54. Effects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitis.
    Cogo R, Castronuovo A.
    Eur Rev Med Pharmacol Sci; 2000 Jan 21; 4(1-2):15-20. PubMed ID: 11409184
    [Abstract] [Full Text] [Related]

  • 55. Effect of bronchodilator aerosols on single-breath ("effective") lung volumes in patients with chronic non-allergic obstructive lung disease.
    Teculescu D.
    Rev Roum Med Intern; 1972 Jan 21; 9(6):559-67. PubMed ID: 4571831
    [No Abstract] [Full Text] [Related]

  • 56. Special problems in respiratory diseases.
    Williams MH.
    Geriatrics; 1974 Jun 21; 29(6):67-71. PubMed ID: 4831396
    [No Abstract] [Full Text] [Related]

  • 57. [Use of dosage-aerosols in the treatment of obstructive respiratory tract diseases].
    Frank A.
    Wien Med Wochenschr; 1977 May 30; 127(10):309-13. PubMed ID: 141791
    [No Abstract] [Full Text] [Related]

  • 58. [Clinical experiences with a new bronchodilator agent (Marax)].
    Paul K.
    Wien Med Wochenschr; 1969 Mar 29; 119(13):252-3. PubMed ID: 5767543
    [No Abstract] [Full Text] [Related]

  • 59. Therapeutic implications of a precise diagnosis of airflow obstruction.
    Picado C.
    Eur Respir J; 1990 Oct 29; 3(9):1091-4. PubMed ID: 1981193
    [No Abstract] [Full Text] [Related]

  • 60. [Principles of theophylline therapy in obstructive respiratory diseases].
    Ukena D, Sybrecht GW.
    Pneumologie; 1992 Feb 29; 46(2):49-51. PubMed ID: 1549553
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.